BA
EBS icon

Boston Advisors’s Emergent Biosolutions EBS Stock Holding History

Boston Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.98M Buy
57,003
+26,122
+85% +$1.22M 0.16% 179
2019
Q2 		$1.49M Sell
30,881
-147
-0.5% -$7.04K 0.08% 268
2019
Q1 		$1.57M Sell
31,028
-8,839
-22% -$521K 0.08% 260
2018
Q4 		$2.36M Sell
39,867
-76,145
-66% -$4.91M 0.14% 185
2018
Q3 		$7.64M Sell
116,012
-2,810
-2% -$164K 0.33% 74
2018
Q2 		$6M Sell
118,822
-34,150
-22% -$1.78M 0.15% 147
2018
Q1 		$8.05M Buy
152,972
+20,640
+16% +$1.03M 0.21% 105
2017
Q4 		$6.15M Buy
132,332
+117,867
+815% +$4.96M 0.13% 180
2017
Q3 		$585K Buy
+14,465
New +$523K 0.01% 455
2017
Q1 		– Sell
-20,685
Closed -$679K – 632
2016
Q4 		$679K Buy
20,685
+8,730
+73% +$262K 0.02% 415
2016
Q3 		$377K Buy
11,955
+3,495
+41% +$102K 0.01% 567
2016
Q2 		$238K Sell
8,460
-12,680
-60% -$497K 0.01% 642
2016
Q1 		$768K Buy
21,140
+4,920
+30% +$174K 0.02% 363
2015
Q4 		$649K Hold
16,220
– – 0.02% 405
2015
Q3 		$462K Buy
16,220
+9,220
+132% +$304K 0.02% 545
2015
Q2 		$231K Buy
+7,000
New +$217K 0.01% 630

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boston Advisors's EBS Position: Q3 2019 in Review

Boston Advisors increased its Emergent Biosolutions (EBS) stake by 85% in Q3 2019, buying an estimated $1.22M and bringing the position to 57,003 shares worth $2.98M. The position accounts for 0.16% of the portfolio, ranked #179.

Boston Advisors first reported a position in EBS in Q2 2015 and has held it in 16 quarters since. The position peaked at $8.05M in Q1 2018. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

  • Boston Advisors held 57,003 shares of Emergent Biosolutions worth $2.98M as of Q3 2019.
  • Boston Advisors bought 26,122 Emergent Biosolutions shares in Q3 2019, an estimated $1.22M.
  • Emergent Biosolutions made up 0.16% of Boston Advisors's portfolio in Q3 2019, its #179 holding.
  • Boston Advisors first reported a position in Emergent Biosolutions in Q2 2015 and has held it in 16 quarters since.
  • Boston Advisors's Emergent Biosolutions position peaked at $8.05M in Q1 2018.
  • 244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.